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Background: DC are among the first antigen presenting cells encountering bacteria at mucosal surfaces, and play
an important role in maintenance of regular homeostasis in the intestine. Upon stimulation DC undergo activation
and maturation and as initiators of T cell responses they have the capacity to stimulate naïve T cells. However,
stimulation of naïve murine DC with B. vulgatus or LPS at low concentration drives DC to a semimature (sm) state
with low surface expression of activation-markers and a reduced capacity to activate T-cells. Additionally,
semimature DC are nonresponsive to subsequent TLR stimulation in terms of maturation, TNF-α but not IL-6
production. Ligation of CD40 is an important mechanism in enhancing DC maturation, function and capacity to
activate T-cells. We investigated whether the DC semimaturation can be overcome by CD40 ligation.
Results: Upon CD40 ligation smDC secreted IL-12p40 but not the bioactive heterodimer IL-12p70. Additionally,
CD40 ligation of smDC resulted in an increased production of IL-6 but not in an increased expression of CD40.
Analysis of the phosphorylation pattern of MAP kinases showed that in smDC the p38 phosphorylation induced by
CD40 ligation is inhibited. In contrast, phosphorylation of ERK upon CD40 ligation was independent of the DC
maturation state.
Conclusion: Our data show that the semimature differentiation state of DC can not be overcome by CD40 ligation.
We suggest that the inability of CD40 ligation in overcoming DC semimaturation might contribute to the
tolerogenic phenotype of semimature DC and at least partially account for maintenance of intestinal immune
homeostasis.
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Dendritic cells (DC) are among the first antigen presen-
ting cells encountering bacteria at mucosal surfaces and
play an important role in maintenance of regular ho-
meostasis in the intestine. Stimulation of DC with e.g.
TLR agonists leads to activation and maturation of DC
by activation of NF-κB and mitogen-activated protein
kinase (MAPK) family members [1]. This results in a
rapid production of costimulatory molecules, cytokines
and pro-inflammatory mediators that affect T-cell diffe-
rentiation, for instance.
We identified Escherichia coli mpk, a commensal E. coli
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reproduction in any medium, provided the orhosts and Bacteroides vulgatus mpk which does not elicit
colitis and even prevents the colitis caused by E. coli mpk
[2,3]. Stimulation of bone marrow derived dendritic cells
(BMDC) with E. coli [4] or lipopolysaccharide (LPS) at
high concentration [5] induced TNF-α, IL-12 and IL-6 se-
cretion and expression of activation-markers, whereas
stimulation with B. vulgatus or [4] LPS at low concentra-
tions [5] only led to secretion of IL-6 and DC were driven
to a semimature state with low expression of activation-
markers. Those semimature DC were nonresponsive to
subsequent TLR stimulation in terms of maturation and
TNF-α but not IL-6 production [4,5]. Moreover, the low
positive expression of activation surface marker like e.g.
CD40 on semimature DC, was not overcome by a subse-
quent stimulus via TLR4 [4]. This might contribute to the
reduced activation of T-cells by semimature DC [4] as
binding of the CD40 ligand (CD40L) on naïve T-cells tol Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and CD8+ T-cell responses [6,7]. CD40 ligation results in
upregulation of CD83, CD80 and CD86 as well as MHC
molecules on DC. Additionally, the expression of adhesion
molecules ICAM-1 and CD58 [8-11] is upregulated and
survival of DC is supported by CD40 ligation [12,13]. Fur-
thermore, CD40 ligation of mature DC results in secretion
of proinflammatory cytokines e.g. IL-1, IL-6 and IL-
12 [9-11] [14,15].
IL-12 plays an important role in T-cell polarization
by promoting Th-1 responses. Its bioactive heterodimer
IL-12p70 consists of a p40 and p35 subunit, which are
encoded by different genes and therefore independently
regulated. IL-12p40 can also form homodimers (IL-12p80)
which were shown to inhibit IL-12p70 mediated immune
responses [16,17].
Mitogen-activated protein kinase (MAPK) signal trans-
duction pathways play a crucial role in many aspects
of immune mediated inflammatory responses [18]. The
MAPK ERK, JNK and p38 are important regulators of
host immune responses to e.g. bacterial stimuli. Extracel-
lular stimuli induce phosphorylation of MAPK–kinase-
kinase (MKKK) which in turn phosphorylate MKK.
Specific MKK are necessary to phosphorylate and ac-
tivate MAPK, which results in activation of down-
stream kinases and transcription factors [18-20]. The
products of inflammatory genes include e.g. cytokines,
chemokines and adhesion molecules which promote re-
cruitment of immunocompetent cells to inflammatory
sites. Additionally, the MAPK p38 enhances the mRNA
stability of many proinflammatory cytokines, e.g. IL-8,
TNF-α or IL-6 [21-23].
Within the present study we analyzed the effects of
DC semimaturation on cellular responses to CD40 li-
gation and showed that the semimature differentiation
state of DC, induced by stimulation with B. vulgatus or
LPSlo can not be overcome by CD40 ligation.
Methods
Mice
C57Bl/6x129sv mice were obtained from own breeding.
All mice were kept under SPF conditions. Male and fe-
male mice were sacrificed at 6–12 weeks of age. Animal
experiments were reviewed and approved by the respon-
sible institutional review committee (Regierungspräsidium
Tübingen, December 19th 2008).
Abs and reagents
Ultra pure LPS Salmonella enterica serovar Minnesota
was purchased from Calbiochem (Schwalbach, Germany).
The following antibodies were used for flow cytometry: PE
conjugated anti-mouse CD11c, clone HL3, Biotin conju-
gated anti-mouse CD40, clone 3/23, Biotin conjugated
anti-mouse CD80, clone 16-10A1, FITC conjugated anti-mouse I-A/I-E clone 2 G9, FITC conjugated anti-mouse
CD86, clone GL1. As isotype control hamster IgG1 λ2,
hamster IgG2a κ and rat IgG2a κ were used. For CD40
ligation we used purified NA/LE hamster anti-mouse
CD40, clone HM40-3, and purified NA/LE hamster IgM,
λ1 isotype control, clone G235-1 (all antibodies from
BD, Heidelberg, Germany). p38 MAP kinase inhibitor
(SB202190) was purchased from Calbiochem (Schwalbach,
Germany), and ERK inhibitor (PD98059) from Promega
(Mannheim, Germany).
Western blotting
For p38 and pERK Western blot analysis proteins (50 μg)
were solubilized in Laemmli sample buffer. They were
separated on SDS-PAGE gels and transferred to nitrocel-
lulose membranes. The membranes were blocked for 1 h
at room temperature in 5% dry milk in TBS/T (TBS con-
taining 2,01% Tween). After that the membranes were
incubated with mouse anti-p38 MAPK (pT180/pY182) or
with mouse anti-ERK 1/2 (pT202/pY204) (both BD Phar-
migen, Heidelberg, Germany) at 4°C over night. The anti-
body solution was diluted 1:1000 in 5% dry milk in TBS/
T. After incubation the membranes were washed three
times in TBS/T and were treated with the secondary anti-
body (polyclonal rabbit anti-mouse conjugated to horse-
radish peroxidase, DakoCytomation, Hamburg, Germany;
diluted 1:1000 in 5% dry milk in TBS/T) for 2.5 h at room
temperature. After repeating the washing step the proteins
were detected by enhanced chemiluminescence. Before
using ß-actin (mouse anti-mouse β-actin; Sigma, Munich,
Germany) as a control for protein loading, the blots were
stripped for 20 min with 10 ml stripping-solution (10 mM
NaOH and 250 mM guanidinium chloride).
Bacteria and cell lines
The bacteria used for stimulation of the murine den-
dritic cells were Escherichia coli mpk [2] and Bacteroides
vulgatus mpk [2] . The E. coli strain was grown in Luria-
Bertani (LB) medium under aerobic conditions at 37°C.
Bacteroides vulgatus was grown in Brain-Heart-Infusion
(BHI) medium and anaerobic conditions at 37°C. In some
experiments, J558L/CD40L cells were used for CD40
ligation. The cells were cultured in DMEM (Dulbecco’s
modified Eagle’s medium,Invitrogen, Darmstadt, Germany)
supplemented with 1 g/l glucose, L-glutamine, pyruvate,
50 μmol/l 2-mercaptoethanol, 10% FCS and penicillin/
streptomycin.
Mouse DC isolation
Bone marrow cells were isolated and cultured as des-
cribed previously [4] with minor modifications. Cells
were harvested at day 7 and used to evaluate the effects
of cellular challenge with E. coli mpk, B. vulgatus mpk
and LPS on subsequent CD40 ligation. Cytokine release
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CD40 ligation as described below.
Stimulation of isolated DC
At day 7, DC were stimulated with viable bacteria at a
MOI of 1 at 37°C, 5% CO2. Gentamicin was added one
hour after stimulation and cells were incubated for 24
hour. To exclude bacterial overgrowth, CFU of viable
bacteria was determined at the end of incubation period.
Respectively, DC were stimulated with LPS (1 ng/ml and
1 μg/ml). After 24 h cell culture supernatant was har-
vested for analysis of cytokine expression and cells were
used for flow cytometry of surface marker expression.
CD40 ligation
To determine the effects of CD40 ligation on DC cyto-
kine production and expression of surface markers DC
were restimulated using an agonistic anti-CD40 mAb
(BD, Heidelberg, Germany). Therefore, DCs pretreated
with E. coli, B. vulgatus or LPS were harvested, washed
twice and cultured at 1.5x105 DC in the presence of
5 μg/ml anti-CD40 mAb in DC culture medium at 37°C,
5% CO2. As a control, DCs were incubated with 5 μg/ml
of the IgM isotype control antibody (BD, Heidelberg,
Germany). After 48 h, DC culture supernatants were
harvested and analyzed for cytokine concentrations by
ELISA. The expression of CD80 and CD86 on the DC
surface was determined by FACS analysis.
For determination of CD40 expression of DC upon
CD40 ligation the J558/LCD40L cell line was irradiated
with 180 Gy in a Gammacell 1000 EliteW (Nordion,
Ottawa, Canada) prior to co-culture with DC. 5x104
J558L/CD40L cells were cultured with 1.5x105 DC in DC
culture medium for 48 h at 37°C, 5% CO2. DC were har-
vested and analyzed for expression of CD40 by FACS.
Inhibition of MAP kinase signaling
DC were incubated with the p38 MAP kinase inhibitor
SB202190 (2 μmol/l) or the ERK inhibitor PD98059
(50 μmol/l) for 30 min prior to CD40 ligation. After
30 min the cells were washed. CD40 ligation with anti
CD40 mAb was performed for 24 h. Cell culture super-
natants were harvested and used for determination of
cytokine concentrations.
Cytokine analysis by ELISA
For analysis of IL-6, IL-12p40 and IL-12p70 concentra-
tions in cell culture supernatants commercially available
ELISA kits (BD, Heidelberg, Germany) were used accor-
ding to the manufacturer’s instructions.
Flow cytometry analysis
3x105 DC were incubated in 150 μl PBS containing 0.5-μl
of fluorochrome conjugated antibodies and applied to flowcytometry analysis. 30,000 cells were analyzed using a
FACS Calibur (BD, Heidelberg, Germany).
Statistical analysis
Statistical analysis was performed using the two sided
unpaired Student’s t-test. P values < 0.05 were considered
significant. Error bars represent ± SEM.
Results
CD40 ligation does not overcome DC semimaturation
Stimulation of DC with B. vulgatus or LPSlo (1 ng/ml)
leads to induction of DC semimaturation [4,5] whereas
stimulation of immature DC with E. coli or LPShi (1 μg/ml)
induces DC maturation. The semimature DC phenotype is
characterized by tolerance towards a subsequent sti-
mulation via TLR2 or TLR4 in terms of TNF-α and
IL-12p70 but not IL-6 secretion and a low positive
expression of costimulatory molecules like e.g. CD40,
CD80 CD86 [4,5]. Herein we investigated whether CD40
ligation as a TLR independent DC activation signal can
overcome the semimature DC phenotype and induce acti-
vation and maturation of semimature DC.
By stimulation of immature DC with B. vulgatus or
LPSlo we induced semimature DC, and by stimulation
with E. coli or LPShi DC maturation was induced. Secre-
tion of IL-12p40 (Figure 1A), IL-12p70 (Figure 1B) and
IL-6 (Figure 1C) was determined by ELISA. CD40 liga-
tion of semimature DC led to secretion of IL-12p40 but
not to secretion of the bioactive heterodimer IL-12p70.
In contrast, CD40 ligation of mature DC resulted in sig-
nificant enhanced secretion of IL-12p70 as compared to
cells treated with the anti-CD40 mAb isotype control.
Mature DC revealed a high spontaneous production of
IL-12p40 which was only slightly enhanced by CD40
ligation (Figure 1A, B). Additionally, CD40 ligation of
semimature DC resulted in increased levels of IL-6
compared to immature DC. In mature DC which also
showed a high spontaneous secretion rate of IL-6 CD40
ligation only led to a slight further increase of IL-6 pro-
duction (Figure 1C).
Next, we investigated whether CD40 ligation can over-
come the low positive expression of DC activation ma-
rkers on semimature DC. Therefore, we analysed the
expression of CD80 (Figure 2A), CD86 (Figure 2B), and
CD40 (Figure 2C) on immature, mature and semimature
DC upon CD40 ligation in comparison to mock cells or
cells treated with the anti-CD40 mAb isotype control by
FACS.
On semimature DC the expression of CD80 was slightly
enhanced upon CD40 ligation, as compared to the control
cells (mock or isotype treated). However, in comparison to
mature DC, in semimature DC the expression of CD80
was still significantly reduced after subsequent CD40
ligation (E. coli 76.7%±1.5% vs. B. vulgatus 37.1%±0.6%;
Figure 1 Cytokine secretion of differentially primed BMDC in response to secondary CD40 ligation. Wildtype BMDC were stimulated with
B. vulgatus mpk (MOI 1) or E. coli mpk (MOI 1) and LPS at low (1 ng/ml) or high concentration (1 μg/ml), respectively, for 24 hour. Unstimulated
DC (PBS) served as a control. Subsequently, these DC were washed twice and were re-stimulated with an agonistic anti-CD40 mAb (5 μg/ml) for
48 hours (black bars). As a control, DC were further incubated in medium only (white bars) or in the presence of the isotype control (grey bars).
The concentrations of IL-12p40 (A), IL-12p70 (B) and IL-6 (C) were determined by ELISA. The bars represent the mean values of three
independent experiments, each performed as duplicate, + SD. * p < 0.05, ** p < 0.01, *** p < 0.001.
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Analysis of the expression of CD86 on immature, semima-
ture and mature DC upon CD40 ligation revealed a slight
increase of CD86 expression in immature (9.1%± 0.5%
to 27.2% ± 4.7%) and semimature DC (B. vulgatus:
20.4% ± 5.1% to 42.5% ± 8.6%; LPSlo 44.3% ± 7.9% to
58.7% ± 9.5%). However, the expression levels of CD86
on semimature DC after CD40 ligation did not reach
the expression levels of mature DC (E. coli: 54.8%± 6.7%
to 59.9%±6.5%; LPShi 56.6%±3.3% to 61.3%± 5.5%)
(Figure 2B).
The MHC class II expression on immature, semima-
ture and mature DC was slightly increased upon CD40
ligation. These changes, however, proved not to be sta-
tistically significant (data not shown).
As anti-CD40 antibodies used for ligation assays and
anti-CD40 antibodies used for FACS analysis might
compete for binding of CD40 we used the J558L/CD40L
cell line to analyze the influence of CD40 ligation on theexpression of CD40 itself on DC. In B. vulgatus treated
semimature DC we found an increase of CD40 expres-
sion upon CD40 ligation (B. vulgatus 26.8%± 7.4% to
55.0%± 0.1%). In LPSlo treated semimature DC we ob-
served a similar effect, however, the increase in CD40
expression was statistically not significant (57.8% ± 6.6%
to 63.5% ± 8.9%). Interestingly, CD40 ligation of se-
mimature DC did not lead to an increase of CD40
resulting in as high expression levels as on mature DC
(E. coli 77.1%±4.2%; LPShi 75.2%±4.0%) (Figure 2C).In DC semimaturation CD40L induced p38
phosphorylation is inhibited
To analyze phosphorylation of the MAP kinase p38 in res-
ponse to CD40 ligation, immature, semimature and ma-
ture DC were activated by CD40 ligation and pp38 levels
were determined by Western blotting. CD40 ligation of
immature and mature DC resulted in phosphorylation of
Figure 2 Expression of CD80, CD86 and CD40 on differentially primed BMDC after secondary CD40 ligation. Wildtype BMDC were
stimulated with B. vulgatus mpk (MOI 1) or E. coli mpk (MOI 1) and LPS at low (1 ng/ml) or high concentration (1 μg/ml), respectively, for 24
hours. Unstimulated DCs (PBS) served as a control. Figure 2A and 2B: The pre-treated DC were washed twice and were re-stimulated with an
agonistic anti-CD40 mAb (5 μg/ml) for 48 hours. As a control, DCs were further incubated in medium only (mock) or in the presence of the
isotype control. The expression levels of CD80 (A) and CD86 (B) were measured by FACS analysis. Figure 2C: The pre-treated DC were washed
twice and were re-stimulated with CD40L by co-culture with J558L/CD40L transfectants or were cultured in medium only as a control
(− J558L/CD40L). After 48 hours, the expression of CD40 was determined by FACS analysis. Each histogram is representative of three independent
experiments. The data are mean values of the percentages of the positive cell populations determined in these three experiments, ± SD.
* p < 0.05, ** p < 0.01, *** p < 0.001; # p < 0.05 compared to the respective control (PBS).
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upon CD40 ligation slightly reduced (Figure 3).
To investigate the biological relevance of p38 MAP
kinase activation we treated immature, semimature and
mature DC with the p38 inhibitor SB202190 prior to
CD40 ligation. Levels of IL-12p40, IL-12p70 and IL-6were determined in cell culture supernatants by ELISA
(Figure 4 A-C).
Inhibition of p38 had no influence on the CD40L
induced secretion of IL-12p40 by DC, independent of
the maturation state (Figure 4A). However, in mature
DC the production of IL-12p70 upon CD40 ligation was
Figure 3 Phosphorylation of p38 MAPK upon secondary CD40 ligation in immature, semimature and mature DC. Wildtype BMDC were
stimulated with B. vulgatus mpk or LPS 1 ng/ml (LPSlow) to generate semimature DC and E. coli mpk or LPS 1 μg/ml (LPShigh), respectively, to
generate mature DC. Immature DC were maintained by incubation in the absence of further stimuli (PBS). After 24 hours, DC were re-stimulated
with anti-CD40 mAb (1 μg/ml) for 15 minutes or treated with the isotype control (Isotype). The expression of pp38 was analyzed by Western
blotting. As loading control, β-actin expression was determined. The results shown are representative of three independent experiments.
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influence the IL-12p70 expression pattern in imma-
ture or semimature DC as CD40 ligation did not induce
any IL-12p70 secretion in these cells (Figure 4B). In ma-
ture DC, both spontaneous and CD40L induced IL-6
secretion levels were partially reduced by inhibition of
the p38 MAP kinase. In contrast, IL-6 production of
immature as well as semimature DC upon CD40 liga-
tion was not significantly affected by inhibition of p38
(Figure 4C).
In DC semimaturation ERK suppresses CD40L induced
IL-12p40 production
To analyze the role of the extracellular signal regulated
kinase (ERK) we used the ERK inhibitor PD98059. Upon
CD40 ligation the inhibition of ERK resulted in a signifi-
cant increase of IL-12p40 in immature and semimature
DC but only a slight increase in mature DC (Figure 5A).
In contrast, inhibition of ERK had not the ability to in-
duce IL-12p70 production in immature and semimature
DC and resulted in only slightly enhanced IL-12p70
secretion levels in mature DC (Figure 5B). The CD40L
induced IL-6 production by DC was not affected by
ERK inhibition, independent of the maturation state
(Figure 5C). In line with this, analysis of pERK levels
upon CD40 ligation of immature, semimature and mature
DC showed similar levels independent of the DC matu-
ration state (data not shown).
Taken together, our data showed that the semimature
differentiation state of DC, induced by stimulation with
B. vulgatus or LPSlo can not be overcome by CD40
ligation.Discussion
In order to clarify the impact of CD40 expression on the
T-cell activation capacity of semimature DC, we exami-
ned the effect of CD40 ligation on immature, semima-
ture and mature DC. Semimature DC were induced by
either stimulation with B. vulgatus or LPS at low con-
centration (1 ng/ml), and are characterized by a low
positive expression of costimulatory molecules like e.g.
CD40, secretion of only IL-6, and nonresponsiveness to-
ward subsequent TLR activation [4,5].
In brief, we showed that CD40 ligation does not over-
come DC semimaturation in terms of expression of acti-
vation surface markers and results in production of only
IL-6 and IL-12p40, but not the bioactive form IL-12p70.
The slightly reduced p38 phosphorylation levels in semi-
mature DC as compared to mature DC might at least
partially contribute to this effect. The expression of
IL-12p40 turned out to be limited by pERK.
In line with other studies [24,25], we observed that on
mature DCs no significant further increase in the ex-
pression levels of the already highly expressed costi-
mulatory molecules CD40, CD80 and CD86 could be
triggered upon additional stimulation by CD40 ligation.
Upon CD40 ligation immature and semimature DC
expressed intermediate levels of CD40 CD80 and CD86,
but did not reach the expression level of mature DC.
However, the intermediate expression of costimulatory
molecules was not associated with production of pro-
inflammatory cytokines like IL-12p70.
It is known that immature DCs characterized by low
expression levels of costimulatory molecules and lacking
secretion of proinflammatory cytokines induce tolerance
Figure 4 Role of p38 MAPK on CD40L induced cytokine secretion in DC of different maturation status. Wildtype BMDC were primed with
B. vulgatus mpk or LPS 1 ng/ml to obtain semimature DC and E. coli mpk or LPS 1 μg/ml, respectively, to obtain mature DC. Immature DC were
maintained by incubation in the absence of further stimuli (PBS). Subsequently, the DC were washed and treated with the p38 inhibitor SB202190
(2 μmol/l, black bars) or as a control with DMSO (grey bars) for 30 minutes, washed and re-stimulated with 1 μg/ml anti-CD40 mAb (+) or the
isotype control (−). After 24 hours, the concentrations of IL-12p40 (A), IL-12p70 (B) and IL-6 (C) were measured in the cell culture supernatants by
ELISA. The bars represent the mean values of three independent experiments, each performed as duplicate, ± SD. * p < 0.05, *** p < 0.001 for
SB202190 compared to DMSO.
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into Treg cells via antigen presentation in the absence of
costimulatory signals [26-29]. Additionally, CD40 defi-
cient DCs or DCs with a suppressed CD40 expression
were shown to have a reduced potential to activate T-cell
proliferation and polarization in Th1 or Th2 direction[30-34]. This effect might also contribute to the inhibited
T-cell activation induced by the intermediate expression
of costimulatory molecules on semimature lamina propria
(lp) DC of B. vulgatus monocolonized IL-2−/− mice [3].
On the other hand it was shown that a high positive
expression of costimulatory molecules in absence of
Figure 5 Role of ERK on CD40L induced cytokine secretion in DC of different maturation status. Wildtype BMDC were primed with
B. vulgatus mpk or LPS 1 ng/ml to obtain semimature DC and E. coli mpk or LPS 1 μg/ml, respectively, to obtain mature DC. Immature DC were
maintained by incubation in the absence of further stimuli (PBS). Subsequently, the DC were washed and treated with the ERK inhibitor PD98059
(50 μmol/l, black bars) or as a control with DMSO (grey bars) for 30 minutes, washed and re-stimulated with 1 μg/ml anti-CD40 mAb (+) or the isotype
control (−). After 24 hours, the concentrations of IL-12p40 (A), IL-12p70 (B) and IL-6 (C) were measured in the cell culture supernatants by ELISA. The
bars represent the mean values of three independent experiments, each performed as duplicate, ± SD. * p< 0.05 for PD98059 compared to DMSO.
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favours T-cell tolerance and suppression of T-cell activa-
tion. This type of DC is mainly induced by autocrine or
paracrine stimulation with inflammatory mediators like
e. g. TNF-α [35-38].
The cytokine secretion pattern upon CD40 ligation
differed between immature/semimature DC and matureDC. In immature and semimature DC, CD40 ligation
did not result in induction of IL-12p70 secretion, in con-
trast to mature DC where CD40 ligation led to increased
IL-12p70 secretion. This is in line with other studies
showing that TLR4 stimulation and CD40 ligation syner-
gize in inducing IL-12 p70 secretion [25,39]. The addi-
tive microbial priming signals are necessary to trigger
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shown to be not induced by exclusive CD40 ligation
[41,42]. Additionally, these accessory stimuli have the
potential to augment the CD40 expression on antigen
presenting cells (APC) [43-45] which results in a more
effective CD40 ligation. However, DC primed with
Bacteroides vulgatus as a microbial stimulus do not
secrete IL-12p70 upon CD40 ligation. This might be
one mechanism accounting for the tolerogenic effects
of B. vulgatus in maintenance of intestinal homeostasis
[2,3]. As Porphyromonas gingivalis which is phylogeneti-
cally closely related to B. vulgatus signals mainly vial
TLR2 [46], this might be also the main receptor for recog-
nition of B. vulgatus. In turn, TLR2 activation is reported
to result in transcription of the p40 but not the p35 sub-
unit of IL-12p70 [1,47]. This might account for the in-
duction of IL-12p40 but not p70 upon stimulation of
B. vulgatus primed DC via CD40 ligation. The production
of IL-12p40 in the absence of the p35 unit might result in
the formation of IL-12p40 homodimers which are known
to act as potent antagonists at the IL-12p70 receptor
[48-50]. Additionally, in IL-12p40 transgenic mice Th1
responses are significantly reduced suggesting that also
in vivo p40 functions as an IL-12 antagonist [51].
Upon CD40 ligation semimature DC produced signifi-
cantly enhanced levels of IL-6 but not TNF-α (data not
shown) or IL-12p70. This is in line with our previous
studies showing a crucial role for IL-6 in induction of
DC semimaturation and tolerance [4,5,52]. This is inter-
esting as the secretion of IL-6 upon CD40 ligation by
semimature DC might help to sustain the semimature
differentiation state and influence the T-cell activation
pattern. IL-6 plays an important role in T-cell differenti-
ation through two independent molecular mechanisms.
First, IL-6 stimulation of T-cells leads to an upregulation
of nuclear factor of activated T cells (NFAT) [53], a tran-
scription factor regulating IL-4 transcription [54] resul-
ting in IL-4 expression, and thereby promotion of Th2
polarized T cell differentiation [55]. Second, IL-6 upre-
gulates the expression of silencer of cytokine signaling
(SOCS) 1 in CD4+ cells which inhibits IFN-γ signaling
and thus Th1 differentiation [56]. The presence of IL-6
may shift the Th1/Th2 balance towards Th2 [55].
CD40 ligation of DC is known to result in phosphory-
lation of MAP kinases like e.g. p38 and ERK [57,58] and
the ratio between pp38 and pERK is thought to play a
crucial role in directing the cytokine secretion pattern of
DC towards pro- or anti-inflammatory host responses
[59-61]. CD40 ligation of mature DC resulted in phos-
phorylation of p38, inhibition of pp38 using the inhibitor
SB202190 partially reduced of IL-12p70 and IL-6 but
not IL-12p40 levels. Therefore, in mature DC pp38 might
contribute to positive regulation of the p35 subunit of
IL-12p70 [62]. This is in line with others showing thatpp38 is important for production of IL-12p70 [61,63].
Additionally, pp38 is known to increase the stability of
IL-6, TNF-α and IL-8 mRNA [22,23,64] which might
result in increased secretion of these cytokines. Further-
more, via the mitogen and stress activated protein kinase
(MSK) 1 pp38 is involved in NFκB activation [65,66]. In
contrast, CD40L induced IL-12p40 secretion from mature
DC has been shown to be independent of p38 phosphory-
lation, but dependent on the NFκB inducing kinase (NIK)
[67].
As we observed an only slight reduction of p38 phos-
phorylation in semimature DC we hypothesize that inhi-
bition of p38 phosphorylation due to DC semimaturation
is only one of many factors that may affect in interaction
with others the cytokine secretion pattern of semimature
dendritic cells in response to secondary CD40 stimulation
and thus their reduced pro-inflammatory capability [3-5].
The slight differences in the MAP kinase phosphorylation
pattern in response to CD40 ligation might be based on
differences in CD40 expression of immature, semimature
or mature DC. A strong CD40 signal is known to prefe-
rentially activate p38, whereas weak CD40 signals are
thought to favour ERK phosphorylation [60].
Inhibition of pERK during CD40 ligation turned out to
have no significant effect of cytokine secretion in mature
DC. In contrast, in semimature DC phosphorylation
of ERK was at least partially responsible for limiting
IL-12p40 expression. This is in line with others showing
similar effects [68]. However, the Western blot analysis
did not reveal significant differences of pERK levels in im-
mature, semimature or mature DC. We speculate that in
semimature DC the ERK activation might probably con-
trol the IL-12p40 production and therefore contribute to
the limitation of the IL-12 p70 production. We are aware
that this is highly speculative and that further work has to
elucidate the role of ERK in DC semimaturation.
Conclusion
We hypothesize that the inability of CD40 ligation in
overcoming DC semimaturation might contribute to the
tolerogenic phenotype of semimature DC and at least par-
tially account for maintenance of intestinal homeostasis.
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